aTyr Pharma | LIFE - Assets

Stock Price
0.85
Daily Change
-0.002 -0.24%
Monthly
-11.97%
Yearly
-69.71%
Q2 Forecast
0.82

aTyr Pharma reported $515.34M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Ardelyx USD 501.6M 15.43M Dec/2025
aTyr Pharma USD 515.34M 408.68M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Curis USD 19.97M 9.27M Dec/2025
Galapagos EUR 3.41B 105.39M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
United Therapeutics USD 7.88B 528.9M Dec/2025
Xoma USD 263.15M 39.7M Sep/2025